The largest study so far which comprised approximately 700 women treated successfully for early stage breast cancer found that elevated levels of CRP measured two and a half years after the time of diagnosis were associated with reduced disease-free and overall survival [23]. The gene discussed is CRP; the disease is breast cancer.